$2.57T
Total marketcap
$177.62B
Total volume
BTC 49.93%     ETH 15.86%
Dominance

Kymera Therapeutics KYMR Stock

39.32 USD {{ price }} -3.104983% {{change_pct}}%
Exchange
NasdaqGM
Market Cap
2.4B USD
LOW - HIGH [24H]
39.08 - 41.24 USD
VOLUME [24H]
931.7K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-2.52 USD

Kymera Therapeutics Price Chart

Kymera Therapeutics KYMR Financial and Trading Overview

Kymera Therapeutics stock price 39.32 USD
Previous Close 25.8 USD
Open 25.58 USD
Bid 0 USD x 1100
Ask 0 USD x 1100
Day's Range 25.58 - 28.43 USD
52 Week Range 14.48 - 39.85 USD
Volume 728.93K USD
Avg. Volume 508.95K USD
Market Cap 1.53B USD
Beta (5Y Monthly) 1.723356
PE Ratio (TTM) N/A
EPS (TTM) -2.52 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 53.94 USD

KYMR Valuation Measures

Enterprise Value 1.09B USD
Trailing P/E N/A
Forward P/E -8.566564
PEG Ratio (5 yr expected) -5.05
Price/Sales (ttm) 32.791233
Price/Book (mrq) 3.2834935
Enterprise Value/Revenue 23.294
Enterprise Value/EBITDA -6.483

Trading Information

Kymera Therapeutics Stock Price History

Beta (5Y Monthly) 1.723356
52-Week Change 75.45%
S&P500 52-Week Change 20.43%
52 Week High 39.85 USD
52 Week Low 14.48 USD
50-Day Moving Average 29.64 USD
200-Day Moving Average 29.06 USD

KYMR Share Statistics

Avg. Volume (3 month) 508.95K USD
Avg. Daily Volume (10-Days) 838.75K USD
Shares Outstanding 55.31M
Float 36.73M
Short Ratio 17.87
% Held by Insiders 7.13%
% Held by Institutions 105.45%
Shares Short 9.24M
Short % of Float 18.95%
Short % of Shares Outstanding 16.71%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -363.50%
Gross Margin -265.39%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -18.018%
Return on Equity (ttm) -35.71%

Income Statement

Revenue (ttm) 46.67M USD
Revenue Per Share (ttm) 0.84 USD
Quarterly Revenue Growth (yoy) -1.60%
Gross Profit (ttm) -117422000 USD
EBITDA -167680000 USD
Net Income Avi to Common (ttm) -159052000 USD
Diluted EPS (ttm) -2.83
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 396.88M USD
Total Cash Per Share (mrq) 7.24 USD
Total Debt (mrq) 68.76M USD
Total Debt/Equity (mrq) 14.88 USD
Current Ratio (mrq) 6.645
Book Value Per Share (mrq) 8.427

Cash Flow Statement

Operating Cash Flow (ttm) -156758000 USD
Levered Free Cash Flow (ttm) -103181376 USD

Profile of Kymera Therapeutics

Country United States
State MA
City Watertown
Address 200 Arsenal Yards Boulevard
ZIP 02472
Phone 857 285 5300
Website https://www.kymeratx.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 174

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, general pustular psoriasis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases and fibrosis; and MDM2 program to treat hematological malignancies and solid tumors. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

Q&A For Kymera Therapeutics Stock

What is a current KYMR stock price?

Kymera Therapeutics KYMR stock price today per share is 39.32 USD.

How to purchase Kymera Therapeutics stock?

You can buy KYMR shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Kymera Therapeutics?

The stock symbol or ticker of Kymera Therapeutics is KYMR.

Which industry does the Kymera Therapeutics company belong to?

The Kymera Therapeutics industry is Biotechnology.

How many shares does Kymera Therapeutics have in circulation?

The max supply of Kymera Therapeutics shares is 61.11M.

What is Kymera Therapeutics Price to Earnings Ratio (PE Ratio)?

Kymera Therapeutics PE Ratio is now.

What was Kymera Therapeutics earnings per share over the trailing 12 months (TTM)?

Kymera Therapeutics EPS is -2.52 USD over the trailing 12 months.

Which sector does the Kymera Therapeutics company belong to?

The Kymera Therapeutics sector is Healthcare.

Kymera Therapeutics KYMR included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD
Nasdaq US 700 Small Cap Index NQUS700SC 2078.81 USD
-0.4
2075.76 USD 2093.28 USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2568.29 USD
+0.16
2566.7 USD 2581.47 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD
NASDAQ Global Market Composite NQGM 2185.85 USD
-0.31
2177.48 USD 2204.21 USD